Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

Shares of vaccine companies fell on Tuesday after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead ...

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

“RSV isn’t reportable, but surveillance shows an uptick in cases. Fortunately, we now have vaccines for older adults and antibody treatments for babies,” Meyerson said. Meyerson ...

Expecting Aussie mums will be entitled to a free vaccine to protect their children from a dangerous virus, as part of a major government health shake-up. RSV commonly causes respiratory infections ...

Pregnant women across Australia will be offered a free vaccine to protect their babies against respiratory syncytial virus (RSV) from next month. The government's $174.5 million investment will ...

Respiratory syncytial virus (RSV) is a leading cause ... levels and to elicit a Th1 immune response. Novavax is testing a postfusion F protein vaccine formulated with alum in both older adults ...

(WLUK) -- Wisconsin health officials confirmed the first pediatric influenza-associated death in the state for the 2024-2025 season. "We are saddened to announce the season's first death of a ...